Biomarker collaboration.nGenomas and Illumina willncollaborate on the design andnvalidationnof genenmarkernpanels.nGenomasnwill use Illumina’s BeadArrayntechnology to identify sets ofndiagnostic biomarkers fornpredicting an individual’snresponse to exercise, diet,nand drug regimens to preventnand treat obesity and itsnrelated metabolic syndrome.
展开▼